1. Snyder JD, Merson MH. The magnitude of the global problem of diarrhoeal disease: a review of active surveillance data. Bulletin of the World Health Organization 1982; 60: 605–613.
2. Bern C, et al. The magnitude of the global problem of diarrhoeal disease: a ten year update. Bulletin of the World Health Organization 1992; 70: 705–714.
3. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bulletin of the World Health Organization 2003; 81: 197–204.
4. Murray C, et al. The Global Burden of Disease 2000 Project: Aims, Methods, and Data Sources. Geneva: World Health Organization, 2001.
5. Parashar UD et al. Global illness and deaths caused by rotavirus disease in children. Emerging Infectious Disease 2003; 9: 565–572.
6. Ruuska T, Vesikari T. A prospective study of acute diarrhoea in Finnish children from birth to 2½ years of age. Acta Paediatrica Scandanvia 1991; 80: 500–507.
7. Pang XL, et al. Human caliciviruses in acute gastroenteritis of young children in the community. Journal of Infectious Diseases 2000; 181 (Suppl. 2): 288–294.
8. Vesikari T, Giaquinto C, Huppertz HI. Clinical trials of rotavirus vaccines in Europe. Pediatric Infectious Disease Journal 2006; 25: S42–S47.
9. Drummond M, et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1997.
10. Iturriza Gomara M, et al. Structured surveillance of infantile gastroenteritis in East Anglia, UK: incidence of infection with common viral gastroenteric pathogens. Epidemiology and Infection 2007. doi:10.1017/S0950268807008059.
11. Rice DP. Estimating the cost of illness. American Journal of Public Health and the Nation's Health 1967; 57: 424–440.
12. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Memorial Fund Quarterly Health and Society 1982; 60: 429–462.
13. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Finance Review 1985; 7: 61–80.
14. Akobundu E, et al. Cost-of-illness studies: a review of current methods. Pharmacoeconomics 2006; 24: 869–890.
15. Netten A, Rees T, Harrison G. Unit Costs of Health and Social Care 2001. PSSRU University of Kent at Canterbury, 2001.
16. The Comptroller and Auditor General. NHS Direct in England. London, 2002.
17. British Medical Association & Royal Pharmaceutical Society of Great Britain. British National Formulary. London: BMJ, 2002.
18. Office for National Statistics. The New Earnings Survey. London, 2002.
19. Soriano-Gabarró M, et al. Burden of rotavirus disease in European Union countries. Pediatric Infectious Disease Journal 2006; 25: S7–S11.
20. PROTECT Advisory Board. The paediatric burden of rotavirus disease in Europe. Epidemiology and Infection 2006; 134: 908–916.
21. Ehlken B, et al. Prospective population-based study on rotavirus disease in Germany. Acta Paediatrica 2002; 91: 769–775.
22. Frühwirth M, et al. A prospective evaluation of community acquired gastroenteritis in paediatric practices: impact and disease burden of rotavirus infection. Archives of Disease in Childhood 2001; 84: 393–397.
23. Frühwirth M, et al. International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection. Pediatric Infectious Disease Journal 2001; 20: 784–791.
24. Laubereau B, et al. Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group [in German]. Schweizerische Medizinische Wochenschrift 1999; 129: 1822–1830.
26. Food Standards Agency. A report of the study of infectious intestinal disease in England. Norwich, 2000.
27. Isaacs D, Day D, Crook S. Childhood gastroenteritis: a population study. British Medical Journal 1986; 293: 545–546.
28. Waters V, et al. Etiology of community-acquired pediatric viral diarrhea: a prospective longitudinal study in hospitals, emergency departments, pediatric practices and child care centers during the winter rotavirus outbreak, 1997 to 1998. The Pediatric Rotavirus Epidemiology Study for Immunization Study Group. Pediatric Infectious Disease Journal 2000; 19: 843–838.
29. Zimmerman CM, et al. Cost of diarrhea-associated hospitalizations and outpatient visits in an insured population of young children in the United States. Pediatric Infectious Disease Journal 2001; 20: 14–19.
30. Frühwirth M, et al. Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in Austria. Pediatric Infectious Disease Journal 2001; 20: 184–188.
31. Buttery J, et al. Clinical and cost impact of rotavirus diarrhoea in Oxfordshire Nurseries and primary care patients. Archives of Disease in Childhood 2001; 84: A61.
32. Roberts JA, et al. The study of infectious intestinal disease in England: socio-economic impact. Epidemiology and Infection 2003; 130: 1–11.
33. Noel JS, et al. Impact of rotavirus infection on a paediatric hospital in the east end of London. Journal of Clinical Pathology 1994; 47: 67–70.
34. Cowden JM. An estimate of the costs of cases of rotavirus infection admitted to hospital in Scotland, 1997. Health Bulletin (Edinburgh) 2001; 59: 188–192.
35. Cooper DL, et al. What can analysis of calls to NHS direct tell us about the epidemiology of gastrointestinal infections in the community? Journal of Infection 2003; 46: 101–105.
36. Lorgelly PK, et al. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the UK. Epidemiology and Infection 2007. doi:10.1017/S0950268807008151.